Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: August 2011

Chapter 9 - Stimulants and psychosis

from Section 3 - Organic syndromes of schizophrenia

Related content

Powered by UNSILO


1. Lieberman J. A., Kinon B. J., Loebel A. D., Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull, 1990. 16(1):97–110.
2. Yui K., Goto K., Ikemoto S., et al. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitisation. Mol, Psychiatry, 1999 Nov. 4(6):512–23.
3. Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitisation. Curr Psychiatry Rep, 2002. 4(3):177–84.
4. Tenn C. C., Fletcher P. J., Kapur S. A putative animal model of the “prodromal” state of schizophrenia. Biol Psychiatry, 2005. 57(6):586–93.
5. Angrist B. M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis– preliminary observations. Biol Psychiatry, 1970. 2(2):95–107.
6. Snyder S. H. Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines. Am J Psychiatry, 1973. 130(1):61–7.
7. Harris D., Batki S. L. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict, 2000. 9(1):28–37.
8. Serper M. R., Chou J. C., Allen M. H., et al. Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation. Schizophr Bull, 1999. 25(2):387–94.
9. Shaner A., Roberts L. J., Eckman T. A., et al. Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatr Serv, 1998. 49(5):684–90.
10. Sato M., Chen C. C., Akiyama K., Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry, 1983. 18(4):429–40.
11. Iwanami A., Sugiyama A., Kuroki N., et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand, 1994. 89(6):428–32.
12. Barnes, T. R., Mutsatsa S. H., Hutton S. B., Watt H. C., Joyce E. M. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry, 2006. 188:237–42.
13. Brady K. T., Sonne S., Randall C. L., Adinoff B., Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend, 1995. 39(1):69–71.
14. Balla A., Sershen H., Serra M., Koneru R., Javitt D. C. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology, 2003. 28(1):34–44.
15. Sato M. A. lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci., 1992. 654:160–70.
16. Nakatani Y., Hara T. Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients. Psychopathology, 1998. 31(3):131–7.
17. Tatetsu S. Methamphetamine psychosis. Folia Psychiatr Neurol Jpn Suppl, 1963. 7:377–80.
18. Barr A. M., Panenka W. J., MacEwan G. W., et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci, 2006. 31(5):301–13.
19. Iyo M., Namba H., Yanagisawa M., et al. Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry, 1997. 21(5):789–96.
20. Farrell M., Boys A., Bebbington P., et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry, 2002. 181:393–8.
21. Floyd A. G., Boutros N. N., Struve F. A., Wolf E., Oliwa G. M. Risk factors for experiencing psychosis during cocaine use: a preliminary report. J Psychiatr Res, 2006. 40(2):178–82. [Epub Jul 26, 2005.]
22. Cherland E., Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatry, 1999. 44(8):811–3.
23. Boutros N. N., Gelernter J., Gooding C. D., et al. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biol Psychiatry, 2002. 51(8):683–6.
24. Schuckit M. A. Comorbidity between substance use disorders and psychiatric conditions. Addiction, 2006. 101(Suppl 1):76–88.
25. Connell P. H. (1958). Amphetamine Psychosis. Maudsley Monographs No. 5. New York: Oxford University Press, pp. 15–36.
26. Bell D. S. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry, 1965. 111:701–7.
27. Ellinwood E. H., Jr. Amphetamine psychosis: I. Description of the individuals and process. J Nervous Mental Disease, 1967. 144:273–83.
28. Charles-Nicolas A. J. [Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts.] Nouv Presse Med, 1976. 5(37):2447–50. French.
29. Yui K., Ikemoto S., Ishiguro T., Goto K. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.] Ann NY Acad Sci, 2000. 914:1–12.
30. Goto, T. [Clinical pictures shown by long hospitalized cases of chronic methamphetamine psychosis: a comparative study with schizophrenia.] Psychiatr Neurol Jpn, 1960. 62:163–76. Japanese.
31. Utena, H., Takano S., Yuasa S., Shimizu T., Kato T. Behavioral abnormalities in animals and metabolic changes in the brain. No To Shinkei, 1961. 13:687–95.
32. Utena H. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res, 1966. 21:192–207.
33. Tomiyama C. Chronic schizophrenia-like states in methamphetamine psychosis. Jpn J Psychiatr Neurol, 1990. 44(3):531–9.
34. Srisurapanont M., Ali R., Marsden J. et al. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol, 2003. 6(4):347–52.
35. Chen C. K., Lin S. K., Sham P. C., et al. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet, 2005. 136(1):87–91.
36. Askevold F. The occurrence of paranoid incidents and abstinence delirium in abusers of amphetamine. Acta Psychiatr Scand, 1959. 34:145–64.
37. Wetli C. V., Fishbain D. A. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci, 1985. 30(3):873–80.
38. Curran C., Byrappa N., McBride A. Stimulant psychosis: systematic review. Br J Psychiatry, 2004. 185:196–204.
39. Gawin F. H. Cocaine addiction: psychology and neurophysiology. Science, 1991. 251(5001):1580–6.
40. Segal D. S., Kuczenski R. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behav Brain Res, 1997. 88(2):251–60.
41. Flaum M., Schultz S.K. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry, 1996. 153(6):812–5.
42. Post R. Cocaine psychoses: a continuum model. Am J Psychiatry, 1975. 132(3):225–31.
43. Satel S. L., Edell W. S. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry, 1991. 148(12):1708–11.
44. Thirthalli J., Benegal V. Psychosis among substance users. Curr Opin Psychiatry, 2006. 19(3):239–45.
45. Rounsaville B. J., Anton S. F., Carroll K., et al. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry, 1991. 48(1):43–51.
46. McLellan A. T., Woody C. E., O'Brien C. P. Development of psychiatric illness in drug abusers: possible role of drug preference. N Eng J Med, 1979. 301:1310–14.
47. Rosse R. B., Collins Jr, Fay-McCarthy M., et al. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study. Clin Neuropharmacol, 1994. 17(4):359–69.
48. Rosenthal R. N., Miner C. R. Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders. Schizophr Bull, 1997. 23(2):187–93.
49. Bartlett E., Hallin A., Chapman B., Angrist B. Selective sensitisation to the psychosis inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology, 1997. 16(1):77–82.
50. Reid M. S., Ciplet D., O'Leary S., Branchey M., Buydens-Branchey L. Sensitisation to the psychosis- inducing effects of cocaine compared with measures of cocaine craving and cue reactivity. Am J Addict, 2004. 13(3):305–15.
51. Unnithan S. B., Cutting J. C. The cocaine experience: refuting the concept of a model psychosis? Psychopathology, 1992. 25(2):71–8.
52. Pencer A., Addington J. Substance use and cognition in early psychosis. J Psychiatr Neurosci, 2003. 28(1):48–54.
53. Iwanami A., Kuroki N., Iritani S., et al. P3a of event-related potential in chronic methamphetamine dependence. J Nerv Ment Dis, 1998. 186(12):746–51.
54. Iwanami A., Suga I., Kaneko T., Sugiyama A., Nakatani Y. P300 component of event-related potentials in methamphetamine psychosis and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 1994. 18(3):465–75.
55. Iwanami, S. A., Kanamori, R. Suga, I. Kaneko, T., Kamijima, K. Reduced attention-related negative potentials in methamphetamine psychosis. J Nerv Ment Dis, 1995. 183(11):693–7.
56. Fein G., Biggins C., MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry, 1996. 39(11):955–65.
57. Adler L. E., Olincy A., Cawthra R. N., et al. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology, 2001. 24(6):671–9.
58. Boutros N. N., Lisanby H. S., Tokuno H., et al. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biol Psychiatry, 2001. 49(4):369–73.
59. Boutros N. N., Lisanby S. H., McClain-Furmanski D., et al. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res, 2005. 39(3):295–302.
60. Bramon E., Rabe-Hesketh S., Sham P., Murray R. M., Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res, 2004. 70(2–3):315–29.
61. Sundaresan K., Ziemann U., Stanley J., Boutros N. N. Cortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation study. Neuro Report. (In Press.)
62. Wiesbeck G. A., Taeschner K. L. A cerebral computed tomography study of patients with drug-induced psychoses. Eur Arch Psychiatry Clin Neurosci, 1991. 241(2):88–90.
63. Robinson T. E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci, 1999. 11(5):1598–604.
64. Wolf M. E. The role of excitatory amino acids in behavioral sensitisation to psychomotor stimulants. Prog Neurobiol, 1998. 54(6):679–720.
65. White F. J., Kalivas P. W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend, 1998. 51(1–2):141–53.
66. Robinson T. E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology, 2004. 47 Suppl 1:33–46.
67. Kalivas P. W., Hu X. T. Exciting inhibition in psychostimulant addiction. Trends Neurosci, 2006. 29(11):610–6. [Epub Sept. 7, 2006.]
68. Strakowski S. M., Sax K. W., Setters M. J., Stanton S. P., Keck P. E. Jr. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitisation model of psychosis in humans. Biol Psychiatry, 1997. 42(9):749–55.
69. Boileau I., Dagher A., Leyton M., et al. Modeling sensitisation to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry, 2006. 63(12):1386–95.
70. Brady K. T., Lydiard R. B., Malcolm R., Cocaine-induced psychosis. J Clin Psychiatry, 1991. 52(12):509–12.
71. Boileau I., Dagher A., Leyton M., et al. Modeling sensitisation to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry, 2006. 63(12):1386–95.
72. Laruelle M. The role of endogenous sensitisation in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev, 2000. 31(2–3):371–84.
73. Beraki S., Aronsson F., Karlsson H., Ogren S. O., Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol Psychiatry, 2005. 10(3):299–308.
74. McNeil T. F., Cantor-Graae E., Ismail B. Obstetric complications and congenital malformation in schizophrenia. Brain Res Brain Res Rev, 2000. 31(2–3):166–78.
75. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res Brain Res Rev, 1994. 19(2):223–39.
76. Beresford T. P., Clapp L. Martin B., et al. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol, 2005. 25(4):363–6.
77. Green A. I., Tohen M. F., Hamer R. M., et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res, 2004. 66(2–3):125–35.
78. Brown E. S., Nejtek V. A., Perantie D.C., Rajan Thomas N., Rush A. J. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol, 2003. 23(4):384–8.
79. Broderick P.A., Rahni D. N., Zhou Y. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog Neuropsychopharmacol Biol Psychiatry, 2003. 27(6):1037–54.
80. Srisurapanont M., Kittiratanapaiboon P., Jarusuraisin N. Treatment for amphetamine psychosis. Cochrane Database Syst Rev, 2001. 4:CD003026.
81. van Os J., Hanssen M., Bijl R. V., Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res, 2000. 45(1–2):11–20.
82. Jones P. B., Bebbington P., Foerster A., et al. Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993. 162:65–71.
83. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry, 1993. 162:80–6.